Compound Screening TRIZ Cases
- Magnetic Cell Levitation System for High-Throughput Density Measurement
A magnetic levitation system balances forces to separate and monitor heterogeneous cell populations in real time.
- CTC Biomarker Detection for Metastatic Prostate Cancer Therapy
Single cell profiling of circulating tumor cells identifies biomarkers linked to abiraterone and enzalutamide response.
- E-cadherin EC2-EC5 Subdomain Targeting for Selective Cancer Therapy
Targeting soluble E-cadherin EC2-EC5 subdomains with antibodies selectively kills cancer cells, avoiding systemic toxicity from non-selective chemotherapeutics.
- CD36 Inhibitors Block Metastasis Stem Cells in Oral Cancer
Anti-CD36 antibodies and shRNA block fatty acid transport to impair metastatic initiation and reduce lymph node tumor size.
- Synaptogyrin-3 Inhibitors for Tauopathy Treatment
Synaptogyrin-3 inhibitors block Tau association with synaptic vesicles, rescuing presynaptic function in tauopathies.
- 3D Collagen Hydrogel for Matrix Vesicle Calcification Imaging
A 3D collagen hydrogel system enables real-time imaging of matrix vesicle calcification.
- LILRB Blocking Antibodies for Myeloid Cell Reprogramming
Segmenting myeloid subsets with LILRB blocking antibodies overcomes PD-1 therapy limitations by reprogramming immunosuppressive cells.
- Kidney-on-a-chip with horizontal multi-compartment structure for renal fibrosis screening
A kidney-on-a-chip device uses a horizontal multi-compartment structure to co-culture renal tubular epithelial cells and fibroblasts.
- Axl-Targeting Antibody-Drug Conjugate for Cancer Treatment
Engineered monoclonal antibody-drug conjugates bind Axl receptors and trigger cellular internalization to deliver cytotoxic payloads.
- Multiplexed Mass Spectrometry for Off-Target Binding Evaluation
A multiplexed mass spectrometry method evaluates binding affinity across multiple receptor targets simultaneously.
- Ion Channel Screening Using Cell Viability Readouts
Cell-based assay replaces fluorescent methods to improve measurement accuracy and throughput for ion channel screening.
- CTP Quantification via Cationic Ion Pairing Chromatography
Cationic ion pairing chromatography coupled with mass spectrometry detects and quantifies cytidine triphosphate levels in cell samples.
- Ion Channel Activity Analysis via Droplet Bilayer Osmosis
Droplet bilayer formation measures ion channel activity via optical detection of volume changes, eliminating cell toxicity and fluorescence noise.
- Macrocyclic Peptides Inhibit PD-L1 Interactions
Macrocyclic peptides block PD-L1 interactions, restoring T cell activity for cancer treatment.
- Biomarker Gene Detection for Contact Normalization Cancer Diagnosis
Analyzing gene expression changes during contact normalization allows accurate diagnosis of metastatic potential while sparing noncancerous cells.
- Monoclonal Antibody for sAPPβ Quantification
Segmented monoclonal antibodies quantify sAPPβ fragments to resolve measurement precision limits in BACE1 activity assessment.
- Porous Transwell Scaffolds for Intestinal Epithelial Monolayers
Porous Transwell membranes mimic the lamina propria to sustain intestinal stem cell proliferation and self-renewal in long-lived monolayers.
- Dynamic Microfluidic Ex Vivo System for Multiple Myeloma Cell Viability
A dynamic microfluidic ex vivo system sustains multiple myeloma cells through continuous nutrient perfusion and 3D bone marrow niche recreation.
- Mutant TSHR Thermostability via Rational Scanning Mutagenesis
Rational scanning mutagenesis enhances mutant TSHR thermostability for stable autoantibody detection.
- Type IV Collagen Peptide for Chronic Nephritis Detection
A type IV collagen-like immunoreactive peptide binds specific chronic nephritis autoantibodies in biological samples.
- CDKL5-Deficient Neuron Models for Rescuing Cellular Defects
Human iPSC-derived neuronal models identify therapeutic compounds that rescue cellular defects in CDKL5 deficiency.
- Soluble CD33 Antagonist Sequesters S100A9 to Block MDSC Activation
Soluble CD33 antagonists sequester S100A9 to block MDSC activation, restoring hematopoiesis and improving therapeutic durability in myelodysplastic syndromes.
- Phosphorylated PD-1 Antibodies for T Cell Pathway Assessment
Specialized antibodies bind phosphorylated PD-1 to resolve detection precision limits in assessing T cell function during immunotherapy.
- Serum Factor Purification for Accurate Inflammatory Models
Purified serum factors reduce inflammatory responses in animal models, resolving the contradiction between model reliability and species resistance.